Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to …

Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …

BCG vaccination in children protects against heterologous infections and improves survival
independently of tuberculosis prevention. The phase III ACTIVATE trial assessed whether …

Background: It was studied if early suPAR-guided anakinra treatment can prevent severe
respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml …

Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing
respiratory tract infection, which can induce respiratory failure and multiple organ dysfunction …

Background A subanalysis of a randomized clinical trial indicated sepsis survival benefit
from interleukin (IL)-1 blockade in patients with features of the macrophage activation-like …

Rationale: Although early antimicrobial discontinuation guided by procalcitonin (PCT) has
shown decreased antibiotic consumption in lower respiratory tract infections, the outcomes in …

Sepsis remains a major cause of morbidity and mortality in both low- and high-income
countries. Antibiotic therapy and supportive care have significantly improved survival following …

The state of immune activation may guide targeted immunotherapy in sepsis. In a double-blind,
double-dummy randomized clinical study, 240 patients with sepsis due to lung infection, …

Background Since the Sepsis-3 criteria, change in Sequential Organ Failure Assessment (SOFA)
score has become a key component of sepsis identification. Thus, it could be argued …